The DOI matches its Crossref record; 118 of the 118 references it cites were found in a registry or an index.
Ovarian Cancer Pathogenesis: A Model in Evolution
Open accessAbstract
Ovarian cancer is a deadly disease for which there is no effective means of early detection. Ovarian carcinomas comprise a diverse group of neoplasms, exhibiting a wide range of morphological characteristics, clinical manifestations, genetic alterations, and tumor behaviors. This high degree of heterogeneity presents a major clinical challenge in both diagnosing and treating ovarian cancer. Furthermore, the early events leading to ovarian carcinoma development are poorly understood, thus complicating efforts to develop screening modalities for this disease. Here, we provide an overview of the current models of ovarian cancer pathogenesis, highlighting recent findings implicating the fallopian tube fimbria as a possible site of origin of ovarian carcinomas. The ovarian cancer model will continue to evolve as we learn more about the genetics and etiology of this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA: A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,188
Microenvironmental regulation of metastasis
Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684 · cited 1×
“Using this FTE coculture system we aim to answer several important questions, including the following: What are the molecular mechanisms driving FTE malignant transformation? Can transformed FTE cells progress to serous tubal intraepithelial carcinoma? Which molecules may be targeted in a therapeutic context to halt s…”
BackgroundIntratumoral T Cells, Recurrence, and Survival in Epithelial Ovarian Cancer
Zhang, L., Conejo-Garcia, J. R., Katsaros, D., Gimotty, P. A., Massobrio, M., Regnani, G., Makrigiannakis, A., Gray, H., Schlienger, K., Liebman, M. N., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa020177 · Cited by 3,397 · cited 1×
“Using this FTE coculture system we aim to answer several important questions, including the following: What are the molecular mechanisms driving FTE malignant transformation? Can transformed FTE cells progress to serous tubal intraepithelial carcinoma? Which molecules may be targeted in a therapeutic context to halt s…”
BackgroundPathology and Genetics of Tumours of the Breast and Female Genital Organs
Tavassoli, F. A., & Devilee, P. (2003) · International Agency for Research on Cancer eBooks · Cited by 2,800
Megabase Chromatin Domains Involved in DNA Double-Strand Breaks in Vivo
Rogakou, E. P., Boon, C., Redon, C., & Bonner, W. M. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.146.5.905 · Cited by 2,422
A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer
Bast, R. C., Klug, T. L., John, E. S., Jenison, E., Niloff, J. M., Lazarus, H., Berkowitz, R. S., Leavitt, T., Griffiths, C. T., Parker, L., et al. (1983) · New England Journal of Medicine · doi:10.1056/nejm198310133091503 · Cited by 2,135
Cannistra, S. A. (2004) · New England Journal of Medicine · doi:10.1056/nejmra041842 · Cited by 2,129
Reactivity of a monoclonal antibody with human ovarian carcinoma.
Bast, R. C., Feeney, M., Lazarus, H., Nadler, L. M., Colvin, R. B., & Knapp, R. C. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110380 · Cited by 1,661
MicroRNA Signatures in Human Ovarian Cancer
Iorio, M. V., Visone, R., Di Leva, G., Donati, V., Petrocca, F., Casalini, P., Taccioli, C., Volinia, S., Liu, C.-G., Alder, H., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1936 · Cited by 1,394
Shih, I.-M., & Kurman, R. J. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63708-x · Cited by 1,206
Kindelberger, D. W., Lee, Y., Miron, A., Hirsch, M. S., Feltmate, C., Medeiros, F., Callahan, M. J., Garner, E. O., Gordon, R. W., Birch, C., et al. (2007) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213335.40358.47 · Cited by 1,113
Benedet, J. L. (2000) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(00)00300-3 · Cited by 1,104
The CA 125 tumour-associated antigen: a review of the literature
Jacobs, I., & Bast, R. C. (1989) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a136832 · Cited by 955
Medeiros, F., Muto, M. G., Lee, Y., Elvin, J. A., Callahan, M. J., Feltmate, C., Garber, J. E., Cramer, D. W., & Crum, C. P. (2006) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000180854.28831.77 · Cited by 916
A candidate precursor to serous carcinoma that originates in the distal fallopian tube
Lee, Y., Miron, A., Drapkin, R., Nucci, M., Medeiros, F., Saleemuddin, A., Garber, J., Birch, C., Mou, H., Gordon, R., et al. (2007) · The Journal of Pathology · doi:10.1002/path.2091 · Cited by 898
Self-citation(2000) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(00)90001-8 · Cited by 891
Moore, R. G., McMeekin, D. S., Brown, A. K., DiSilvestro, P., Miller, M. C., Allard, W. J., Gajewski, W., Kurman, R., Bast, R. C., & Skates, S. J. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.08.031 · Cited by 875
Mutations in BRAF and KRAS Characterize the Development of Low-Grade Ovarian Serous Carcinoma
Singer, G., Oldt, R., Cohen, Y., Wang, B. G., Sidransky, D., Kurman, R. J., & Shih, I.-M. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.6.484 · Cited by 854
Menon, U., Gentry-Maharaj, A., Hallett, R., Ryan, A., Burnell, M., Sharma, A., Lewis, S., Davies, S., Philpott, S., Lopes, A., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70026-9 · Cited by 829
Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
Köbel, M., Kalloger, S. E., Boyd, N., McKinney, S., Mehl, E., Palmer, C., Leung, S., Bowen, N. J., Ionescu, D. N., Rajput, A., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050232 · Cited by 814 · cited 1×
“A recent immunohistochemical biomarker study of 500 ovarian carcinomas found that 20 of 21 candidate tumor biomarkers had significantly different expression patterns in each tumor subtype and that two thirds of the biomarkers lost their prognostic value when survival analyses were made subtype specific [66].”
BackgroundSugiyama, T., Kamura, T., Kigawa, J., Terakawa, N., Kikuchi, Y., Kita, T., Suzuki, M., Sato, I., & Taguchi, K. (2000) · Cancer · doi:10.1002/1097-0142(20000601)88:11<2584::aid-cncr22>3.0.co;2-5 · Cited by 795
Piek, J. M. J., van Diest, P. J., Zweemer, R. P., Jansen, J. W., Poort‐Keesom, R. J. J., Menko, F. H., Gille, J. J. P., Jongsma, A. P. M., Pals, G., Kenemans, P., et al. (2001) · The Journal of Pathology · doi:10.1002/path.1000 · Cited by 787
Boyle, P., & Levin, B. L. (2009) · Cited by 770
Cheng, J. Q., Godwin, A. K., Bellacosa, A., Taguchi, T., Franke, T. F., Hamilton, T. C., Tsichlis, P. N., & Testa, J. R. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.19.9267 · Cited by 736
The Raf/MEK/ERK pathway: new concepts of activation
Peyssonnaux, C., & Eychène, A. (2001) · Biology of the Cell · doi:10.1016/s0248-4900(01)01125-x · Cited by 735
The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma.
Hellström, I., Raycraft, J., Hayden-Ledbetter, M. S., Ledbetter, J. A., Schummer, M., McIntosh, M. W., Drescher, C. W., Urban, N. D., & Hellström, K. E. (2003) · PubMed · Cited by 711
Ras and TGFβ cooperatively regulate epithelial cell plasticity and metastasis
Janda, E., Lehmann, K., Killisch, I., Jechlinger, M., Herzig, M., Downward, J., Beug, H., & Grünert, S. (2002) · The Journal of Cell Biology · doi:10.1083/jcb.200109037 · Cited by 706
Moore, R. G., Brown, A. K., Miller, M. C., Skates, S., Allard, W. J., Verch, T., Steinhoff, M., Messerlian, G., DiSilvestro, P., Granai, C. O., et al. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.10.017 · Cited by 695
Risch, H. A., McLaughlin, J. R., Cole, D. E. C., Rosen, B., Bradley, L., Fan, I., Tang, J., Li, S., Zhang, S., Shaw, P. A., et al. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj465 · Cited by 680
In search of the tumour-suppressor functions of BRCA1 and BRCA2
Scully, R., & Livingston, D. M. (2000) · Nature · doi:10.1038/35044000 · Cited by 643
Wooster, R., & Weber, B. L. (2003) · New England Journal of Medicine · doi:10.1056/nejmra012284 · Cited by 605
Dinulescu, D. M., Ince, T. A., Quade, B. J., Shafer, S. A., Crowley, D., & Jacks, T. (2005) · Nature Medicine · doi:10.1038/nm1173 · Cited by 604
Kabawat, S. E., Bast, R. C., Bhan, A. K., Welch, W. R., Knapp, R. C., & Colvin, R. B. (1983) · International Journal of Gynecological Pathology · doi:10.1097/00004347-198303000-00005 · Cited by 588
Drapkin, R., von Horsten, H. H., Lin, Y., Mok, S. C., Crum, C. P., Welch, W. R., & Hecht, J. L. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3924 · Cited by 570
Self-citationScreening for ovarian cancer: a pilot randomised controlled trial
Jacobs, I. J., Skates, S. J., MacDonald, N., Menon, U., Rosenthal, A. N., Davies, A. P., Woolas, R., Jeyarajah, A. R., Sibley, K., Lowe, D. G., et al. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10261-1 · Cited by 560
The Histologic Type and Stage Distribution of Ovarian Carcinomas of Surface Epithelial Origin
Seidman, J. D., Horkayne-Szakaly, I., Haiba, M., Boice, C. R., Kurman, R. J., & Ronnett, B. M. (2004) · International Journal of Gynecological Pathology · doi:10.1097/01.pgp.0000101080.35393.16 · Cited by 554
The mTOR/PI3K and MAPK pathways converge on eIF4B to control its phosphorylation and activity
Shahbazian, D., Roux, P. P., Mieulet, V., Cohen, M. S., Raught, B., Taunton, J., Hershey, J. W., Blenis, J., Pende, M., & Sonenberg, N. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601166 · Cited by 531
Pathology and classification of ovarian tumors
Chen, V. W., Ruiz, B., Killeen, J. L., Cot�, T. R., Wu, X. C., Correa, C. N., & Howe, H. L. (2003) · Cancer · doi:10.1002/cncr.11345 · Cited by 506
Ovarian carcinoma diagnosis: Results of a national ovarian cancer survey
Goff, B. A., Mandel, L., Muntz, H. G., & Melancon, C. H. (2000) · Cancer · doi:10.1002/1097-0142(20001115)89:10<2068::aid-cncr6>3.0.co;2-z · Cited by 502
Early Events in the Pathogenesis of Epithelial Ovarian Cancer
Landen, C. N., Birrer, M. J., & Sood, A. K. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.9970 · Cited by 462
Schwartz, D. R., Kardia, S. L. R., Shedden, K., Kuick, R. D., Michailidis, G. C., Taylor, J. M. G., Misek, D. E., WU, R. T., Zhai, Y., Darrah, D. M., et al. (2002) · PubMed · Cited by 430
Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors.
OBATA, K., Morland, S. J., Watson, R. H., Hitchcock, A., Chenevix‐Trench, G., Thomas, E. J., & Campbell, I. (1998) · PubMed · Cited by 429
New Insights Into the Pathogenesis of Serous Ovarian Cancer and Its Clinical Impact
Levanon, K., Crum, C., & Drapkin, R. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.1107 · Cited by 412 · cited 2×
“The clinical implications of this model were recently reviewed [111, 113] and suggest that a thorough examination of the fallopian tube fimbria should be conducted during routine pathologic evaluations of salpingo-oophorectomy specimens.”
BackgroundSelf-citationSinger, G., Stöhr, R., Cope, L., Dehari, R., Hartmann, A., Cao, D.-F., Wang, T.-L., Kurman, R. J., & Shih, I.-M. (2005) · American Journal of Surgical Pathology · doi:10.1097/01.pas.0000146025.91953.8d · Cited by 408 · cited 10×
“Lee et al.’s study also made several key observations about the relationship between p53 signatures and TICs: 1 p53 signatures occur more frequently in fimbriae where TICs are also present, 2 p53 signatures are composed exclusively of secretory cells which, like TICs, exhibit a serous phenotype, 3 p53 signatures and T…”
BackgroundInfluentialMalignancy in Endometriosis: Frequency and Comparison of Ovarian and Extraovarian Types
Stern, R. C., Dash, R., Bentley, R. C., Snyder, M. J., Haney, A. F., & Robboy, S. J. (2001) · International Journal of Gynecological Pathology · doi:10.1097/00004347-200104000-00004 · Cited by 403
Zorn, K. K., Bonome, T., Gangi, L., Chandramouli, G. V. R., Awtrey, C. S., Gardner, G. J., Barrett, J. C., Boyd, J., & Birrer, M. J. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0508 · Cited by 376
Finch, A., Shaw, P., Rosen, B., Murphy, J., Narod, S. A., & Colgan, T. J. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2005.06.065 · Cited by 375
The cell of origin of ovarian epithelial tumours
Dubeau, L. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70308-5 · Cited by 363
Segregation of receptor and ligand regulates activation of epithelial growth factor receptor
Vermeer, P. D., Einwalter, L. A., Moninger, T. O., Rokhlina, T., Kern, J. A., Zabner, J., & Welsh, M. J. (2003) · Nature · doi:10.1038/nature01440 · Cited by 359
Induction of ovarian cancer by defined multiple genetic changes in a mouse model system
Orsulic, S., Li, Y., Soslow, R. A., Vitale-Cross, L. A., Gutkind, J. S., & Varmus, H. E. (2002) · Cancer Cell · doi:10.1016/s1535-6108(01)00002-2 · Cited by 358
The Efficacy of Transvaginal Sonographic Screening in Asymptomatic Women at Risk for Ovarian Cancer
van Nagell, J. R., DePriest, P. D., Reedy, M. B., Gallion, H. H., Ueland, F. R., Pavlik, E. J., & Kryscio, R. J. (2000) · Gynecologic Oncology · doi:10.1006/gyno.2000.5816 · Cited by 345
Diverse Tumorigenic Pathways in Ovarian Serous Carcinoma
Singer, G., Kurman, R. J., Chang, H.-W., Cho, S. K. R., & Shih, I.-M. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62549-7 · Cited by 340
Epidemiology of Ovarian Cancer
Permuth-Wey, J., & Sellers, T. A. (2009) · Methods in Molecular Biology · doi:10.1007/978-1-60327-492-0_20 · Cited by 326
Sabbah, M., Emami, S., Redeuilh, G., Julien, S., Prévost, G., Zimber, A., Ouelaa, R., Bracke, M., De Wever, O., & Gespach, C. (2008) · Drug Resistance Updates · doi:10.1016/j.drup.2008.07.001 · Cited by 322
Bonome, T., Lee, J.-Y., Park, D.-C., Radonovich, M., Pise-Masison, C., Brady, J., Gardner, G. J., Hao, K., Wong, W. H., Barrett, J. C., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-2240 · Cited by 319
Flesken‐Nikitin, A., Choi, K., Eng, J. P., Shmidt, E. N., & Nikitin, A. Y. (2003) · PubMed · Cited by 315
Wu, R., Hendrix-Lucas, N., Kuick, R., Zhai, Y., Schwartz, D. R., Akyol, A., Hanash, S., Misek, D. E., Katabuchi, H., Williams, B. O., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.02.016 · Cited by 313
Connolly, D. C., Bao, R., Nikitin, A. Y., Stephens, K. C., Poole, T. W., Xiang, H., Harris, S. S., Vanderhyden, B. C., & Hamilton, T. C. (2003) · PubMed · Cited by 310
Serum HE4 concentration differentiates malignant ovarian tumours from ovarian endometriotic cysts
Huhtinen, K., Suvitie, P., Hiissa, J., Junnila, J., Huvila, J., Kujari, H., Setälä, M., Härkki, P., Jalkanen, J., Fraser, J., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605011 · Cited by 297
Folkins, A. K., Jarboe, E. A., Saleemuddin, A., Lee, Y., Callahan, M. J., Drapkin, R., Garber, J. E., Muto, M. G., Tworoger, S., & Crum, C. P. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.01.012 · Cited by 293
Self-citationPathologic Findings in Prophylactic Oophorectomy Specimens in High-Risk Women
Leeper, K., Garcia, R., Swisher, E., Goff, B., Greer, B., & Paley, P. (2002) · Gynecologic Oncology · doi:10.1006/gyno.2002.6779 · Cited by 292
Seidman, J. D., & Kurman, R. J. (1996) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199611000-00004 · Cited by 290
p53 gene mutations and protein accumulation in human ovarian cancer.
Kupryjańczyk, J., Thor, A. D., Beauchamp, R., Merritt, V, Edgerton, S. M., Bell, D. A., & Yandell, D. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.4961 · Cited by 289
Histologic Transformation of Benign Endometriosis to Early Epithelial Ovarian Cancer
Sainz de la Cuesta, R., Eichhorn, J. H., Rice, L. W., Fuller, Jr., Nikrui, N., & Goff, B. A. (1996) · Gynecologic Oncology · doi:10.1006/gyno.1996.0032 · Cited by 272
Zurawski, V. R., Orjaseter, H., Andersen, A., & Jellum, E. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910420507 · Cited by 268
Dubeau, L. (1999) · Gynecologic Oncology · doi:10.1006/gyno.1998.5275 · Cited by 262
Lerner, J. P., Timor-Tritsch, I. E., Federman, A., & Abramovich, G. (1994) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(13)70284-9 · Cited by 261
Skates, S. J. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.955 · Cited by 256
Czernobilsky, B., Moll, R., Levy, R., & Franke, W. W. (1985) · PubMed · Cited by 244
Ovarian and extraovarian endometriosis-associated cancer
Modesitt, S. (2002) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(02)02149-x · Cited by 242
Bourne, T. H., Campbell, S., Reynolds, K. M., Whitehead, M. I., Hampson, J., Royston, P., Crayford, T. J., & Collins, W. P. (1993) · BMJ · doi:10.1136/bmj.306.6884.1025 · Cited by 240
Ovarian cancer screening with annual transvaginal sonography: Findings of 25,000 women screened
van Nagell, J. R., DePriest, P. D., Ueland, F. R., DeSimone, C. P., Cooper, A. L., McDonald, J. M., Pavlik, E. J., & Kryscio, R. J. (2007) · Cancer · doi:10.1002/cncr.22594 · Cited by 217
Kurman, R. J., Visvanathan, K., Roden, R., Wu, T. C., & Shih, I.-M. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.01.005 · Cited by 203
Auersperg, N., Maines‐Bandiera, S., Dyck, H. G., & Kruk, P. A. (1994) · PubMed · Cited by 189
Spectrum of Mutation and Frequency of Allelic Deletion of the p53 Gene in Ovarian Cancer
Kohler, M. F., Marks, J. R., Wiseman, R. W., Jacobs, I. J., Davidoff, A. M., Clarke-Pearson, D. L., Soper, J. T., Bast, R. C., & Berchuck, A. (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.18.1513 · Cited by 184
The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer
Fishman, D. A., Cohen, L., Blank, S. V., Shulman, L., Singh, D., Bozorgi, K., Tamura, R., Timor-Tritsch, I., & Schwartz, P. E. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.01.041 · Cited by 173
Bcl-2 and p53 Protein Expression, Apoptosis, and p53 Mutation in Human Epithelial Ovarian Cancers
Chan, W.-Y., Cheung, K.-K., Schorge, J. O., Huang, L.-W., Welch, W. R., Bell, D. A., Berkowitz, R. S., & Mok, S. C. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64744-x · Cited by 171
Eržen, M., Rakar, S., Klančar, B., & Syrjänen, K. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2001.6382 · Cited by 160 · cited 2×
“Clear cell and endometrioid carcinomas, unlike other subtypes, are strongly linked to endometriosis [52–56], leading some to believe that endometriosis may be a precursor to these lesions [57, 58].”
BackgroundItamochi, H., Kigawa, J., Sugiyama, T., Kikuchi, Y., Suzuki, M., & Terakawa, N. (2002) · Obstetrics and Gynecology · doi:10.1016/s0029-7844(02)02040-9 · Cited by 155
Skates, S. J., Ankerst, D. P., & Jacobs, I. J. (2001) · Journal of the American Statistical Association · doi:10.1198/016214501753168145 · Cited by 150
CA125 expression pattern, prognosis and correlation with serum CA125 in ovarian tumor patients
Høgdall, E. V. S., Christensen, L. H., Kjær, S. K., Blaakær, J., Kjærbye‐Thygesen, A., Gayther, S. A., Jacobs, I. J., & Høgdall, C. K. (2006) · Gynecologic Oncology · doi:10.1016/j.ygyno.2006.09.028 · Cited by 144
Early Detection of Ovarian Cancer: Promise and Reality
Bast, R. C., Urban, N. D., Shridhar, V., Smith, D., Zhang, Z., Skates, S. J., Lu, K. H., Liu, J., Fishman, D. A., & Mills, G. B. (2002) · Cancer treatment and research · doi:10.1007/978-1-4757-3587-1_3 · Cited by 143
p53 Mutations and Expression in Ovarian Cancers: Correlation with Overall Survival
Wen, W., Reles, A., Runnebaum, I. B., Sullivan‐Halley, J., Bernstein, L., Jones, L. A., Felix, J. C., Kreienberg, R., El‐Naggar, A. K., & Press, M. F. (1999) · International Journal of Gynecological Pathology · doi:10.1097/00004347-199901000-00005 · Cited by 143
Sehdev, A. E. S., Sehdev, P. S., & Kurman, R. J. (2003) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200306000-00003 · Cited by 142
Endometrioid Adenocarcinoma of the Ovary and Its Relationship to Endometriosis
McMeekin, D. S., Burger, R. A., Manetta, A., DiSaia, P. J., & Berman, M. L. (1995) · Gynecologic Oncology · doi:10.1006/gyno.1995.1271 · Cited by 140
Ovarian cancer: Can we make the clinical diagnosis earlier?
Smith, L. H., Morris, C. R., Yasmeen, S., Parikh‐Patel, A., Cress, R. D., & Romano, P. S. (2005) · Cancer · doi:10.1002/cncr.21310 · Cited by 138
Carcangiu, M. L., Radice, P., Manoukian, S., Spatti, G., Gobbo, M., Pensotti, V., Crucianelli, R., & Pasini, B. (2003) · International Journal of Gynecological Pathology · doi:10.1097/01.pgp.0000101082.35393.84 · Cited by 136
Identifying symptoms of ovarian cancer: a qualitative and quantitative study
Bankhead, C. R., Collins, C., Stokes-Lampard, H. J., Rose, P. W., Wilson, S., Clements, A., Mant, D., Kehoe, S. T., & Austoker, J. (2008) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2008.01772.x · Cited by 135
Nustad, K., Bast, R. C., Brien, T. J. O. R., Nilsson, O., Seguin, P., Suresh, M. R., Saga, T., Nozawa, S., Børmer, O. P., de Bruijn, H. W. A., et al. (1996) · Tumor Biology · doi:10.1159/000217982 · Cited by 133
Combining multiple serum tumor markers improves detection of stage I epithelial ovarian cancer
Zhang, Z., Yu, Y., Xu, F., Berchuck, A., van Haaften‐Day, C., Havrilesky, L. J., de Bruijn, H. W. A., van der Zee, A. G. J., Woolas, R. P., Jacobs, I. J., et al. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.08.009 · Cited by 128
CA 125 in Benign Gynecological Conditions
Meden, H., & Fattahi-Meibodi, A. (1998) · The International Journal of Biological Markers · doi:10.1177/172460089801300411 · Cited by 125
Murdoch, W. J., & Martinchick, J. F. (2004) · Experimental Biology and Medicine · doi:10.1177/153537020422900613 · Cited by 122
Precursors to pelvic serous carcinoma and their clinical implications
Folkins, A. K., Jarboe, E. A., Roh, M. H., & Crum, C. P. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.01.013 · Cited by 119
Prevalence of Endometriosis in Ovarian Cancer
Yoshikawa, H., Jimbo, H., Okada, S., Matsumoto, K., Onda, T., Yasugi, T., & Taketani, Y. (2000) · Gynecologic and Obstetric Investigation · doi:10.1159/000052873 · Cited by 115
Ovarian cancer: a focus on management of recurrent disease
Herzog, T. J., & Pothuri, B. (2006) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0637 · Cited by 112
Kruk, P. A., Uitto, V., Firth, J. D., et al. (1994) · Experimental Cell Research · doi:10.1006/excr.1994.1320 · Cited by 109
Caduff, R. F., Svoboda-Newman, S. M., Ferguson, A. W., Johnston, C. M., & Frank, T. S. (1999) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199903000-00012 · Cited by 102
Molecular Genetic Defects in Endometriosis
Thomas, E. J., & Campbell, I. (2000) · Gynecologic and Obstetric Investigation · doi:10.1159/000052878 · Cited by 102
Prospective Study of Serum CA-125 Levels as Markers of Ovarian Cancer
Helzlsouer, K. J. (1993) · JAMA · doi:10.1001/jama.1993.03500090059033 · Cited by 97
Early events in ovarian epithelial carcinogenesis: progress and problems in experimental approaches
Auersperg, N., Ota, T., & Mitchell, G. W. E. (2002) · International Journal of Gynecological Cancer · doi:10.1046/j.1525-1438.2002.01152.x · Cited by 95
Comer, M. T., Leese, H. J., & Southgate, J. (1998) · Human Reproduction · doi:10.1093/humrep/13.11.3114 · Cited by 90
Serial propagation of human ovarian surface epithelium in tissue culture
Siemens, C. H., & Auersperg, N. (1988) · Journal of Cellular Physiology · doi:10.1002/jcp.1041340305 · Cited by 89
Gadducci, A., Zola, P., Landoni, F., Maggino, T., Sartori, E., Bergamino, T., & Cristofani, R. (1995) · Gynecologic Oncology · doi:10.1006/gyno.1995.1181 · Cited by 88
Risk factors for a serous cancer precursor (“p53 signature”) in women with inherited BRCA mutations
Saleemuddin, A., Folkins, A. K., Garrett, L. A., Garber, J. E., Muto, M. G., Crum, C. P., & Tworoger, S. S. (2008) · Gynecologic Oncology · doi:10.1016/j.ygyno.2008.07.018 · Cited by 82
Ross, J. S., Yang, F., Kallakury, B., Sheehan, C. E., Ambros, R. A., & Muraca, P. J. (1999) · American Journal of Clinical Pathology · doi:10.1093/ajcp/111.3.311 · Cited by 72
Establishment and characterization of an immortalized human oviductal cell line
Lee, Y. L., Lee, C., Xu, J., Wang, Y., Tsao, S., & Yeung, W. S. B. (2001) · Molecular Reproduction and Development · doi:10.1002/mrd.1046 · Cited by 72
Drapkin, R., Crum, C. P., & Hecht, J. L. (2004) · Human Pathology · doi:10.1016/j.humpath.2004.04.014 · Cited by 70
Self-citationOrtiz, B. H., Ailawadi, M., Colitti, C., Muto, M. G., Deavers, M. T., Silva, E. G., Berkowitz, R. S., Mok, S. C., & Gershenson, D. M. (2001) · PubMed · Cited by 68
Kenemans, P., van Kamp, G. J., Oehr, P., & Verstraeten, R. A. (1993) · Clinical Chemistry · doi:10.1093/clinchem/39.12.2509 · Cited by 61
Hawkins, R. E., Roberts, K., Wiltshaw, E., MUNDY, J., Fryatt, I. J. C., & McCready, V. R. (1989) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1989.tb06301.x · Cited by 60
Establishment of human ampullary cell cultures
Bongso, A., Ng, S. C., Sathananthan, H., Lian, N. P., Rauff, M., & Ratnam, S. S. (1989) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a136932 · Cited by 45
Analysis of Gene Expression in Early-Stage Ovarian Cancer
Marchini, S., Mariani, P., Chiorino, G., Marrazzo, E., Bonomi, R., Fruscio, R., Clivio, L., Garbi, A., Torri, V., Cinquini, M., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0523 · Cited by 44
p53 autoantibodies, cytokine levels and ovarian carcinogenesis
Tsai-Turton, M., Santillan, A., Lü, D., Bristow, R. E., Chan, K. C. G., Shih, I., & Roden, R. B. S. (2009) · Gynecologic Oncology · doi:10.1016/j.ygyno.2009.03.028 · Cited by 38
Early diagnosis and predictors of malignancy of adnexal masses
Murta, E. F. C., & Nomelini, R. S. (2006) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/01.gco.0000192967.67567.e9 · Cited by 36
Umezu, T., Hanazono, M., Aizawa, S., & Tomooka, Y. (2003) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-003-0009-9 · Cited by 33
Epithelial cells from human Fallopian tube in culture
Henriksen, T., Tanbo, T. G., Åbyholm, T., Oppedal, B. R., Clausen, O. P. F., & Hovig, T. (1990) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a137034 · Cited by 30
Establishment of a ciliated epithelial cell line from human Fallopian tube
Ando, H., Kobayashi, M., Toda, S., Kikkawa, F., Masahashi, T., & Mizutani, S. (2000) · Human Reproduction · doi:10.1093/humrep/15.7.1597 · Cited by 25
Pathogenesis of Ovarian Cancer
Drapkin, R., & Hecht, J. L. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-0764-9.00024-x · Cited by 17
Self-citation
Cited by
Lheureux, S., Gourley, C., Vergote, I., & Oza, A. M. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32552-2 · Cited by 1,919
High grade serous ovarian carcinomas originate in the fallopian tube
Labidi-Galy, S. I., Papp, E., Hallberg, D., Niknafs, N., Adleff, V., Noe, M., Bhattacharya, R., Novak, M., Jones, S., Phallen, J., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00962-1 · Cited by 759
Self-citationIron addiction: a novel therapeutic target in ovarian cancer
Basuli, D., Tesfay, L., Deng, Z., Paul, B., Yamamoto, Y., Ning, G., Xian, W., McKeon, F., Lynch, M., Crum, C. P., et al. (2017) · Oncogene · doi:10.1038/onc.2017.11 · Cited by 465
A Comprehensive Analysis of PAX8 Expression in Human Epithelial Tumors
Laury, A. R., Perets, R., Piao, H., Krane, J. F., Barletta, J. A., French, C., Chirieac, L. R., Lis, R., Loda, M., Hornick, J. L., et al. (2011) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318216c112 · Cited by 460
Self-citationPathogenesis and heterogeneity of ovarian cancer
Kroeger, P. T., & Drapkin, R. (2017) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000340 · Cited by 314
Self-citation
Metadata
- Authors
- Karst, A. M., & Drapkin, R.
- Venue
- Journal of Oncology
- Publisher
- Wiley
- Published
- 2010
- Volume
- 2010
- Pages
- 1-13
- ISSN
- 1687-8450 (ISSN-L)
- 1687-8469
- OpenAlex
- W2005071828
- Cited by
- 298
- References
- 118
- FWCI
- 23.97
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.